Published in Neurology on March 10, 2010
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain (2011) 1.36
Cerebral and muscle MRI abnormalities in myotonic dystrophy. Neuromuscul Disord (2012) 1.08
Therapeutics development in myotonic dystrophy type 1. Muscle Nerve (2011) 1.07
Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol Med (2011) 1.07
Evaluation of CNS involvement in myotonic dystrophy type 1 and type 2 by transcranial sonography. J Neurol (2014) 0.99
White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study. Neuromuscul Disord (2010) 0.96
The neglected brain in myotonic dystrophy types 1 and 2. Neurology (2010) 0.91
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy. Front Mol Neurosci (2014) 0.87
Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage. PLoS One (2014) 0.85
Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour. Brain (2013) 0.84
Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1. J Neurol Sci (2014) 0.82
Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2. J Neurol (2014) 0.81
Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness. PLoS One (2015) 0.80
Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy. Hum Gene Ther (2013) 0.80
Brain MRI abnormalities in the adult form of myotonic dystrophy type 1: A longitudinal case series study. Neuroradiol J (2016) 0.77
In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8. BMC Neurol (2016) 0.76
Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2. Neurol Sci (2016) 0.76
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study. Orphanet J Rare Dis (2016) 0.76
Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects. Neurol Sci (2017) 0.76
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1. Neuroimage Clin (2016) 0.76
Cortical Thickness and White Matter Integrity are Associated with CTG Expansion Size in Myotonic Dystrophy Type I. Yonsei Med J (2017) 0.75
Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1. Neuroimage Clin (2016) 0.75
Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS. Front Cell Neurosci (2017) 0.75
Establishing functional speech in echolalic children. Behav Res Ther (1967) 11.82
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med (1996) 6.05
A pilot basic education program for school dropouts incorporating a token reinforcement system. Behav Res Ther (1968) 4.94
Persistent solar influence on North Atlantic climate during the Holocene. Science (2001) 4.79
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol (1998) 4.61
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Inbreeding avoidance in animals. Trends Ecol Evol (1996) 3.79
Approaches to sudden death from coronary heart disease. Circulation (1971) 3.58
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Voltage-gated ion channels and hereditary disease. Physiol Rev (1999) 2.76
DNA copy number losses in human neoplasms. Am J Pathol (1999) 2.73
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest (1981) 2.52
Bat flight generates complex aerodynamic tracks. Science (2007) 2.50
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
Membrane changes in cells from myotonia patients. Physiol Rev (1985) 2.38
Acute mercury poisoning (acrodynia) mimicking pheochromocytoma in an adolescent. J Pediatr (1993) 2.37
The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol (1996) 2.37
Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost (1992) 2.31
Leading-edge vortex improves lift in slow-flying bats. Science (2008) 2.24
A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet (1994) 2.22
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy. Neurology (2010) 2.16
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med (2000) 2.15
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 2.09
Artifactual pulse-oximetry estimation in neonates. Lancet (1994) 2.04
The pef fimbrial operon of Salmonella typhimurium mediates adhesion to murine small intestine and is necessary for fluid accumulation in the infant mouse. Infect Immun (1996) 2.04
Terahertz spin current pulses controlled by magnetic heterostructures. Nat Nanotechnol (2013) 2.01
Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet (1993) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve (1987) 1.94
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology (2007) 1.90
Genotype-phenotype correlations in human skeletal muscle sodium channel diseases. Arch Neurol (1993) 1.88
Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol (1997) 1.84
A model for intracellular translocation of protein kinase C involving synergism between Ca2+ and phorbol esters. Nature (1985) 1.83
Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol (1993) 1.82
Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain (2001) 1.82
Investigation of human brain hemodynamics by simultaneous near-infrared spectroscopy and functional magnetic resonance imaging. Med Phys (2001) 1.81
Phase-specific modulation of cortical motor output during movement observation. Neuroreport (2001) 1.77
[Nuclear medicine in Europe: education]. Nuklearmedizin (2012) 1.76
Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release. J Physiol (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 1.73
Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci U S A (1989) 1.73
Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol (1996) 1.73
[Biosynthesis of 6-methylsalicylic acid]. Eur J Biochem (1970) 1.70
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol (1993) 1.68
Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet (1994) 1.67
GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology (2012) 1.67
Lautropia mirabilis gen. nov., sp. nov., a gram-negative motile coccus with unusual morphology isolated from the human mouth. Microbiology (1994) 1.66
Shewanella alga bacteremia in two patients with lower leg ulcers. Clin Infect Dis (1996) 1.66
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer. Lung Cancer (2003) 1.63
Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut (2001) 1.63
Role of intracellular calcium mobilization in the regulation of protein kinase C-mediated membrane processes. Nature (1985) 1.61
Interaction of protein kinase C with membranes is regulated by Ca2+, phorbol esters, and ATP. J Biol Chem (1985) 1.61
Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight. Thromb Haemost (2001) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging (2010) 1.59
Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost (1995) 1.58
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology (2011) 1.58
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol (1999) 1.58
Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58
Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature (1990) 1.57
Whole-body high-field MRI shows no skeletal muscle degeneration in young patients with recessive myotonia congenita. Acta Neurol Scand (2009) 1.57
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand (1997) 1.57
Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci U S A (1986) 1.56
Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant (2011) 1.56
Myotonia fluctuans. Arch Neurol (1990) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Transient electronic structure and melting of a charge density wave in TbTe3. Science (2008) 1.56
Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion. Anesth Analg (1999) 1.56
Mechanism of voltage-dependent gating in skeletal muscle chloride channels. Biophys J (1996) 1.56
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology (1994) 1.55
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet (1989) 1.54
Near-infrared study of fluctuations in cerebral hemodynamics during rest and motor stimulation: temporal analysis and spatial mapping. Med Phys (2000) 1.54
The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology (2006) 1.54
K(+)-aggravated myotonia: destabilization of the inactivated state of the human muscle Na+ channel by the V1589M mutation. J Physiol (1994) 1.54
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med (1999) 1.53
The dup(3q) syndrome: report of eight cases and review of the literature. Am J Med Genet (1981) 1.52
Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve (2000) 1.50
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 procedures. Epilepsy Behav (2008) 1.50
Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circ Res (1998) 1.49
Associations between leprosy and serum protein groups. Humangenetik (1970) 1.47
Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med (2001) 1.47
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney Int (2006) 1.45
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease. Kidney Int (2008) 1.44
Further observations of true mosaic trisomy 17 ascertained in amniotic fluid cell cultures. Prenat Diagn (1998) 1.44
Hypokalemic periodic paralysis: in vitro investigation of muscle fiber membrane parameters. Muscle Nerve (1984) 1.44